fructosamine has been researched along with glucagon-like peptide 1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bache, M; Holst, JJ; Højberg, PV; Knop, FK; Krarup, T; Madsbad, S; Rabøl, R; Vilsbøll, T | 1 |
| Arrigo, M; Beauvais, F; Cohen-Solal, A; Launay, JM; Logeart, D; Nougué, H; Pezel, T; Picard, F; Sadoune, M; Vodovar, N | 1 |
| Acosta, A; Burton, D; Calderon, G; Camilleri, M; Davis, J; Gedulin, B; Gribble, FM; LaRusso, NF; Linker-Nord, S; McRae, A; Reimann, F; Rievaj, J; Roberts, G; Vella, A; Zandvakili, I | 1 |
1 trial(s) available for fructosamine and glucagon-like peptide 1
| Article | Year |
|---|---|
Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes.
Topics: Administration, Oral; Bile Acids and Salts; Biological Transport; Blood Glucose; Capsules; Cell Line; Cholestenones; Colon; Diabetes Mellitus, Type 2; Diffusion Chambers, Culture; Enteroendocrine Cells; Fasting; Fibroblast Growth Factors; Fructosamine; Gene Expression; Glucagon-Like Peptide 1; Homeostasis; Humans; Ileum; Insulin; Obesity; Postprandial Period; Primary Cell Culture; Receptors, G-Protein-Coupled | 2020 |
2 other study(ies) available for fructosamine and glucagon-like peptide 1
| Article | Year |
|---|---|
Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Fructosamine; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Infusions, Intravenous; Insulin; Male; Middle Aged; Reference Values | 2009 |
Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study.
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Atrial Natriuretic Factor; Biphenyl Compounds; CD146 Antigen; Chronic Disease; Dose-Response Relationship, Drug; Drug Combinations; Echocardiography; Female; Fructosamine; Glucagon-Like Peptide 1; Heart Failure; Humans; Interleukin-1 Receptor-Like 1 Protein; Male; Middle Aged; Natriuretic Peptide, Brain; Neprilysin; Peptide Fragments; Substance P; Tetrazoles; Treatment Outcome; Troponin I; Valsartan | 2019 |